March 23, 2024

Cocoa Prices Soar as Industry Faces Unprecedented Crisis

Cocoa prices have hit record highs due to poor harvests in West Africa and ongoing challenges like underinvestment and insufficient farmer support. This has led to what industry leaders are calling a cocoa crisis, putting the global supply of chocolate at risk. At the heart of the crisis are the skyrocketing costs of cocoa, which… [Read More]
March 23, 2024

Cocoa Prices Soar as Industry Faces Unprecedented Crisis

Cocoa prices have hit record highs due to poor harvests in West Africa and ongoing challenges like underinvestment and insufficient farmer support. This has led to what industry leaders are calling a cocoa crisis, putting the global supply of chocolate at risk. At the heart of the crisis are the skyrocketing costs of cocoa, which… [Read More]
March 23, 2024

The Next Blockbuster? FDA Approvals in 2024

Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers,… [Read More]
March 22, 2024

Trump’s Truth will go public as DWAC shareholders approve merger

On Friday, a merger involving Donald Trump’s social media company and Digital World Acquisition Corp. (DWAC) got the green light from DWAC shareholders. This merger could potentially earn Trump a hefty profit of around $3 billion. The approval follows about two and a half years after DWAC, a special purpose acquisition company, disclosed its plans… [Read More]
March 22, 2024

Axial Therapeutics Investigates Gut-Brain Connection in Autism

Privately-held biotechnology company, Axial Therapeutics, is investigating the gut-brain connection as it advances a treatment for Autism Spectrum Disorder (ASD). The company’s lead product candidate, AB-2004, is a first-in-class oral gut-targeted small molecule therapeutic designed to treat irritability associated with autism. The compound is formulated as a powder that can be mixed with food for… [Read More]
March 22, 2024

PRISM Market Moves on Friday: FedEx Gains; lululemon and Nike Slump

US equities are trading slightly lower on Friday at midday following a strong session on Thursday with the Dow, S&P, and Nasdaq each hitting a fresh record close. Big tech is mixed, with Tesla ($TSLA) underperforming. Other weak performers include retail/apparel, department stores, EVs, asset managers, tobacco, regional banks, and media, while outperformers include parcels… [Read More]
March 22, 2024

Alles Gute, Germany!! Canopy Growth Soars 75% This Week as German Cannabis Legislation Passes

PRISM Cannabis Index leader, Canopy Growth Corporation (CGC), a globally renowned diversified cannabis enterprise, commends the final approval by the German government legalizing cannabis, marking a significant milestone in advancing enhanced access to medical cannabis. Effective April 1, 2024, cannabis will formally be recognized as non-narcotic in Germany, signifying a pivotal shift in both legal… [Read More]
March 22, 2024

Rare Pediatric Disease Designation for Lisata’s Osteosarcoma Candidate

Lisata Therapeutics (Nasdaq: LSTA) has been granted Rare Pediatric Disease Designation by the FDA for LSTA1, the company’s lead product candidate, for the treatment of osteosarcoma, a rare cancer that can develop in children, adolescents and young adults. LSTA1 has demonstrated favorable safety, tolerability, and activity in clinical trials. The company’s share price settled up… [Read More]
March 22, 2024

Stocks making the biggest moves premarket: Reddit, Nike, FedEx and more

Take a glance at companies that were in the limelight before the market opened. Nike — The stock experienced a 6.2% dip following the famed footwear company’s announcement of decelerating growth in China during fiscal Q3 2024, although it surpassed quarter earnings and revenue expectations, buoyed by North American sales and price adjustments. Lululemon —… [Read More]